News & Commentary
Latest News Features
- Blank check company Quinpario Acquisition Corp files and sets terms for $150 million IPO
- Blank check company Quinpario Acquisition Corp files and sets terms for $150 million IPO
- KAR Auction Services, Inc (KAR) Ex-Dividend Date Scheduled for June 20, 2013
- Huaneng Power International, Inc. (HNP) Ex-Dividend Date Scheduled for June 20, 2013
Latest News Videos
Moving the Market |
|
Market Summary | | Stocks On The Move |
6/19/2013 1:30 PM ET
[BRIEFING.COM][BRIEFING.COM] So far, it has been much ado about nothing today, yet that is about to change with the release of the FOMC policy directive at the top of the hour and Fed Chairman Bernanke's press conference following at 2:30 p.m. ET. The indices...[more]
Stock Market Headlines
LightSquared Lenders Say Company Avoiding Terms of Settlement 1:52PM ET - Dow Jones Business News
GM Hits High Marks in J.D. Power Quality Survey 1:45PM ET - Dow Jones Business News
Judge Rules for Verizon in $9 Billion Lawsuit Over Spinoff 1:45PM ET - Dow Jones Business News
Pentagon Seeks $13.7 Million From Boeing Over Parts Charges -Bloomberg 1:33PM ET - Dow Jones Business News
The Blue Note Jazz Festival to Ring The NASDAQ Stock Market Closing Bell 1:22PM ET - GlobeNewswire
View AllBrowse News by Category
RSS user?
Market Musings
Market Currents
Real-time news and commentary for investors
- 1:53 PM Neurocrine Biosciences ([[NBIX]] +2.7%) moves up today after being initiated by Oppenheimer with an Outperform rating. The firm says that its sees blockbuster potential for elagolix, with Phase 3 endometriosis results expected in H114 and Phase 2 results in H214. A secondary asset, NBI-98854, a Vesicular Mono-Amine Transporter 2 compound for treating tardive dyskinesia, is risky, but only modest value is baked in.
- See All Market Currents